ABSCIENCES (EPA:AB) AB Science today announced that results from masitinib study AB12005 in pancreatic cancer, have been selected for presentation at the upcoming ASCO Annual Meeting
Transparency directive : regulatory news
20/05/2021 18:06
ABSCIENCES's latest news
15/05/2024 20:16
13/03/2024 12:58
07/03/2024 15:20
06/03/2024 20:21
29/02/2024 11:49
26/02/2024 18:32
28/11/2023 19:22
27/11/2023 08:04
29/09/2023 19:49
18/09/2023 18:05
Other stories
16/05/2024 23:18
16/05/2024 22:45
16/05/2024 23:01
16/05/2024 19:04
16/05/2024 12:14
17/05/2024 00:56
16/05/2024 18:35
16/05/2024 22:32
16/05/2024 23:28
16/05/2024 18:42
16/05/2024 22:03
16/05/2024 16:32
16/05/2024 14:41
16/05/2024 18:43
16/05/2024 19:43
Former Post Office executive tells Horizon inquiry she blocked Paula Vennells’ number - The Guardian
16/05/2024 20:39
16/05/2024 20:10
16/05/2024 13:42
16/05/2024 18:24
16/05/2024 12:13
16/05/2024 16:07
16/05/2024 20:27
16/05/2024 18:00
16/05/2024 23:09
16/05/2024 18:53
16/05/2024 16:32
16/05/2024 21:36
16/05/2024 23:22
16/05/2024 21:35
17/05/2024 00:23
15/05/2024 22:40
16/05/2024 09:24
15/05/2024 11:19
16/05/2024 21:46
16/05/2024 17:46
16/05/2024 13:00
16/05/2024 10:02
16/05/2024 10:15